Articles By Nushin Rashidian

Regulation, United States

In Rescheduling Comments, Cannabis Regulators Offer Support, Ask for Clarity, and Share Experiences

Individual state governors and the National Conference of State Legislatures shared support, too.

Regulation, United States

In Rescheduling Comments, Transport, Safety, and Alcohol Groups Spotlight Impairment Concerns

Major groups like AAA and the National Transportation Safety Board commented on cannabis rescheduling.

Regulation, United States

Cannabis Rescheduling Comments: What Did Justice, Law Enforcement, Labor, and Religious Groups Say?

The Center for American Progress, the Southern Baptist Convention, and the United Food and Commercial Workers International Union submitted comments.

Regulation, United States

Medical and Research Groups Call for Funding, Clarity on Synthetics Cannabinoids in Rescheduling Comments

The American Medical Association, the University of California system, and the Epilepsy Foundation submitted comments.

Regulation

Pres. Biden Formally Announces DOJ Will Move to Reclassify Cannabis

Now, the public will have a chance to weigh in on cannabis rescheduling.

Regulation

In Historic Move, DEA Will Recommend Cannabis Reclassification

The rescheduling of cannabis, once complete, will mark an historic shift in U.S. cannabis policy, and is likely to send ripple effects across the globe.

Germany

Germany’s Adult Use Cannabis Law Takes Effect. Now What?

After two years, the push by Chancellor Olaf Scholz’s government to legalize cannabis has cleared its first big step.

Germany

Germany’s Federal Council Vote Clears the Way for Cannabis Legalization to Take Effect April 1

The Federal Council voted Friday to pass the bill, which already cleared Parliament last month, dispelling fears that the Council would push for amendments and delay legalization.

United States

Kamala Harris Hosts Cannabis Roundtable, Calls Current Federal Policy “Absurd” 

In a White House conversation focused on cannabis pardons, Harris also urged the DEA to move "as quickly as possible" on its review of how the federal government classifies cannabis.